학술논문

High-dose alectinib for RET fusion-positive non-small cell lung cancer in the Blood First Assay Screening Trial
Document Type
article
Source
Contemporary Oncology, Vol 27, Iss 4, Pp 217-223 (2024)
Subject
alectinib
blood-based assay
blood first assay screening trial (bfast)
non small cell lung cancer
nsclc
ret fusion
ctdna
circulating tumour dna
liquid biopsy
ngs
Medicine
Language
English
ISSN
1428-2526
1897-4309